Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Multicenter Phase II Study to Evaluate Efficacy and Safety of P276-00 in Indian Subjects With Recurrent, Metastatic or Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck

NCT00824343 is registered in ClinicalTrials.gov with Piramal Enterprises Limited as lead sponsor.

NCT NCT00824343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00824343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Multicenter Phase II Study to Evaluate Efficacy and Safety of P276-00 in Indian Subjects With Recurrent, Metastatic or Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck
Lead sponsor
Piramal Enterprises Limited
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2008
Completion date
June 30, 2013
Enrollment
86 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

squamous cell carcinoma of head and neck